Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 13 of the 29 sources its claims cite were checked for support.
Abstract
In many cells and specially in muscle, mitochondria form elongated filaments or a branched reticulum. We show that Mfn2 (mitofusin 2), a mitochondrial membrane protein that participates in mitochondrial fusion in mammalian cells, is induced during myogenesis and contributes to the maintenance and operation of the mitochondrial network. Repression of Mfn2 caused morphological and functional fragmentation of the mitochondrial network into independent clusters. Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak. We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression. In all, our data indicate that Mfn2 expression is crucial in mitochondrial metabolism through the maintenance of the mitochondrial network architecture, and reduced Mfn2 expression may explain some of the metabolic alterations associated with obesity.
Overview
CoChat Summary
TL;DR
Mitofusin-2 (Mfn2), a mitochondrial membrane protein induced during myogenesis, is required to maintain the elongated, intralumenally connected mitochondrial network in muscle cells and to sustain mitochondrial metabolism. Mfn2 expression is reduced in skeletal muscle of obese Zucker rats and obese humans, suggesting its loss contributes to the metabolic alterations of obesity.
Key findings
- Mfn2 mRNA (4.7 kb) is predominant in skeletal muscle and heart, and Mfn2 mRNA and protein are markedly induced during L6E9 myoblast differentiation into myotubes, in parallel with development of an extensive mitochondrial network.
- Antisense repression of Mfn2 in L6E9 myotubes (≈50% reduction in mitochondrial extracts) fragmented the network: 82% of mitochondrial filaments were longer than 5 µm in control cells versus only 22% in antisense cells. Laser microirradiation showed loss of membrane potential spread across the whole network in controls but only a very reduced extension in antisense myotubes.
- Mfn2 repression reduced mitochondrial function: glucose oxidation fell by 30% in myotubes and by 30% (or 70% per the Discussion) in 10T1/2 antisense clones; mitochondrial membrane potential fell by nearly 60%; oxygen consumption fell 30%, with coupled respiration unchanged and proton-leak-linked respiration significantly reduced.
- In obesity, Mfn2 mRNA was 34% lower in Zucker obese rats and 36% lower in obese humans; Mfn2 protein was 39% lower (rats) and 43% lower (humans). Obese rat muscle showed higher mitochondrial density (11.2 ± 0.6 vs 8.2 ± 0.5 organelles/10 µm², p < 0.001), 42% greater total mitochondrial surface area, and 25% lower volume per unit area, consistent with a smaller, fragmented network.
Methods
- Differential screening by PCR-select cDNA subtraction on gastrocnemius muscle from obese (fa/fa) versus lean (fa/+) Zucker rats isolated the 321-bp C31 clone, identified as Mfn2; expression was confirmed by Northern blot, competitive-quantitative RT-PCR, and Western blot with an anti-Mfn2 peptide antibody.
- Human samples: vastus lateralis biopsies from 13 healthy lean volunteers (51 ± 2 years; BMI 23 ± 1 kg/m²; insulin 34 ± 2 pmol/liter) and 9 obese volunteers (46 ± 2 years; BMI 34 ± 1 kg/m²; insulin 62 ± 6 pmol/liter), taken before a 3-h euglycemic hyperinsulinemic clamp (insulin 12 pmol/kg/min); obese subjects showed 50% lower insulin-stimulated glucose disposal (4.9 ± 0.8 vs 10.1 ± 1.1 mg/kg/min).
- Functional work used transient Mfn2 overexpression and antisense knockdown (stable transfection in 10T1/2 fibroblasts; adenoviral antisense in L6E9 myotubes), with confocal immunofluorescence/MitoTracker/JC-1 imaging, laser microirradiation, electron microscopy, [¹⁴C]glucose oxidation, and Clark-electrode respiration measurements; mitochondrial volume/surface area in soleus muscle was quantified by the vertical sections stereological method (4 obese and 4 lean rats, 80 photographs/group at 5,000×).
Limitations
- The paper states that further studies in rodents after recombinant ablation of Mfn2 are required to determine whether it contributes to obesity, and it notes that the mechanism by which Mfn2 supports respiratory chain activity is only postulated (destabilization/reduced activity of certain complexes), not demonstrated.
- The authors note that not all L6E9 myoblasts differentiate in culture (≈30% remain undifferentiated) and that undifferentiated myoblasts are not infected by adenovirus, so the observed reduction in glucose oxidation after antisense infection is a substantial underestimate of the actual inhibition.
- Evident from the text: the human data are cross-sectional and correlational (n = 13 lean, 9 obese), so causality between reduced Mfn2 and obesity-related metabolic alterations is not established; the mitochondrial network/morphology measurements in obesity were made only in Zucker rats, not in human muscle.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 0 Not valid · 8 Not checked · 69 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression.”
- Also stated in: § Abstract · plain
“We also show that this regulatory mechanism is disturbed in obesity.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In myoblast cells, a short portion of a mitochondrial filament became de-energized when one of the cluster-composing mitochondria was damaged by laser (Fig. 3,C and D). As a consequence of the loss of mitochondrial membrane potential, mitochondria became unstained by JC-1.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under these conditions, we found that myogenesis caused the induction of Mfn2 protein in L6E9 cells (Fig. 2C).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 84 claims and every source verdict.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipid overloading promotes fast and transient changes in mitochondrial architecture.”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with the above observations, obese patients display a largely fragmented mitochondrial network in skeletal muscle (Bach et al, 2003).”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mfn2 is a nuclear-encoded mitochondrial protein that shows homology with Drosophila or yeast Fzo proteins (26,27) and is highly expressed in skeletal muscle, the heart, and the brain (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and mitochondria from obese Zucker rats show higher mitochondrial surface, lower mitochondrial volume, and a lower extent of the mitochondrial network (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ RESULTS
“Repression of Mfn2 in 10T1/2 cells also reduced glucose oxidation by 307 (Fig. 8C).”
§ DISCUSSION
“cellular repression of Mfn2 in 10T1/2 cells (687 reduction) reduces mitochondrial proton leak and cellular oxygen consumption (307 reduction) and glucose oxidation (707 reduction)”
Citations
Cites
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446
Alexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Estimation of surface area from vertical sections
Baddeley, A. J., Gundersen, H. J. G., & Cruz‐Orive, L. M. (1986) · Journal of Microscopy · doi:10.1111/j.1365-2818.1986.tb04282.x · Cited by 1,058
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Control of mitochondrial morphology by a human mitofusin
Santel, A., & Fuller, M. T. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.867 · Cited by 1,012
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
A Human Dynamin-related Protein Controls the Distribution of Mitochondria
Smirnova, E., Shurland, D.-L., Ryazantsev, S. N., & van der Bliek, A. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.351 · Cited by 733
Research works printed but not linked: 3
- Astrup, 1987, Int. J. Obesity, 11, 51
- Kaplan, 1991, Int. J. Obesity, 15, 809
- Buchberger, 1996, Am. J. Physiol., 271, R472
Cited by
Items 401–500 of 829
Mitochondrial fragmentation and network architecture in degenerative diseases
Shah, S. I., Paine, J. G., Perez, C., & Ullah, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223014 · Cited by 43
Mitochondria: Joining forces to thwart cell death
Jahani‐Asl, A., Germain, M., & Slack, R. S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.006 · Cited by 44
“Specific roles for MFN2 include modulation of metabolism by affecting the electron transport chain [15,16] and tethering of endoplasmic reticulum to mitochondria [17].”
Boushel, R., & Saltin, B. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.024 · Cited by 45
Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
Sorriento, D., Pascale, A. V., Finelli, R., Carillo, A. L., Annunziata, R., Trimarco, B., & Iaccarino, G. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/604685 · Cited by 43
“Obesity in both humans and rodents is associated with reduced levels of mitofusin, involved in docking to initiate fusion [51], and polymorphisms of presenillin-associated rhomboid-like (PARL) protein, important for morphologic integrity [52].”
BackgroundRetractedCharacterization of distinct single-channel properties of Ca2+ inward currents in mitochondria
Bondarenko, A. I., Jean-Quartier, C., Malli, R., & Graier, W. F. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1224-1 · Cited by 38
“, VDAC [2, 23] or mitofusin-2 [1, 5, 16]) interact with the Ca channels of the inner mitochondrial membrane and, subsequently, affect their Fig.”
Rocha‐Rodrigues, S., Rodríguez, A., Becerril, S., Ramírez, B., Gonçalves, I. O., Beleza, J., Frühbeck, G., Ascensão, A. A. M. R., & Magalhães, J. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12706 · Cited by 44
Four days of bed rest increases intrinsic mitochondrial respiratory capacity in young healthy males
Larsen, S., Lundby, A. M., Dandanell, S., Oberholzer, L., Keiser, S., Andersen, A. B., Haider, T., & Lundby, C. (2018) · Physiological Reports · doi:10.14814/phy2.13793 · Cited by 40
“MFN2 protein content has previously been reported reduced in patients with type 2 diabetes and obese insulin-resistant subjects (Bach et al. 2003, 2005) indicating that the mitochondrial dynamics could be important in the development of impaired glucose tolerance and type 2 diabetes.”
BackgroundTomas, C., Brown, A. E., Newton, J. L., & Elson, J. L. (2019) · PeerJ · doi:10.7717/peerj.6500 · Cited by 43
MiD49 and MiD51: New mediators of mitochondrial fission and novel targets for cardioprotection.
Samangouei, P., Crespo-Avilan, G. E., Cabrera-Fuentes, H. A., Hernández‐Reséndiz, S., Ismail, N. I., Katwadi, K., Boisvert, W. A., & Hausenloy, D. J. (2018) · Conditioning medicine · Cited by 46
Cerqueira, F. M., von Stockum, S., Giacomello, M., Goliand, I., Kakimoto, P. A., Marchesan, E., Stefani, D. D., Kowaltowski, A. J., Ziviani, E., & Shirihai, O. S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101676 · Cited by 41
Ruegsegger, G. N., Pataky, M. W., Simha, S., Robinson, M. M., Klaus, K. A., & Nair, K. S. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00405.2023 · Cited by 38
Adaptations of Skeletal Muscle Mitochondria to Obesity, Exercise, and Polyunsaturated Fatty Acids
Chen, P. B., Yang, J. S., & Park, Y. (2018) · Lipids · doi:10.1002/lipd.12037 · Cited by 37
Hypothalamic redox balance and leptin signaling - Emerging role of selenoproteins
Gong, T., Torres, D. J., Berry, M. J., & Pitts, M. W. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.02.038 · Cited by 41
Cai, H., Chen, L., Zhang, M., Xiang, W., & Su, P. (2018) · Placenta · doi:10.1016/j.placenta.2018.08.005 · Cited by 36
Zeng, Y., Pan, Q., Wang, X., Li, D., Lin, Y., Man, F., Xiao, F., & Guo, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4508762 · Cited by 41
“First, mitochondrial fusion and fission undergo changes under hyperglycemic conditions in a variety of cell types, including endothelial cells [20, 21], pancreatic β cells [41, 42], and skeletal muscle cells [43].”
BackgroundNikpour, M., Pellagatti, A., Liu, A., Karimi, M., Malcovati, L., Gogvadze, V. G., Forsblom, A., Wainscoat, J. S., Cazzola, M., Zhivotovsky, B., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08174.x · Cited by 37
“MFN2 participates in the mitochondrial pathway and its silencing leads to enhanced apoptosis in HeLa cells (Sugioka et al, 2004) and reduced mitochondrial membrane potential (Bach et al, 2003).”
BackgroundMetabolic manipulators: a well founded strategy to combat mitochondrial dysfunction
Koene, S., & Smeitink, J. A. M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9162-y · Cited by 41
“Lipid peroxidation as a consequence of an increased ROS production changes the structural architecture of the mitochondrial network (Bach et al. 2003; Hood 2001), and is generally accompanied by changes in mitochondrial content, ultrastructure, and enzyme levels (Rossignol et al.”
BackgroundPendin, D., Filadi, R., & Pizzo, P. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00102 · Cited by 39
“On the same line, inactivation of pro-fusion proteins inhibits oxidative metabolism (24, 25), though the mechanism is not completely clear and may involve unbalanced partitioning of mtDNA.”
BackgroundXin, Y., Wu, W., Qu, J., Wang, X., Song, L., Yuan, L., & Liu, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3649808 · Cited by 36
Hashem, K. S., Abdelazem, A. Z., Mohammed, M. A., Nagi, A. M., Aboulhoda, B. E., Mohammed, E. T., & Abdel‐Daim, M. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-11313-x · Cited by 35
RetractedGuillet, V., Guéguen, N., Verny, C., Ferré, M., Homedan, C., Loiseau, D., Procaccio, V., Amati‐Bonneau, P., Bonneau, D., Reynier, P., et al. (2009) · Neurogenetics · doi:10.1007/s10048-009-0207-z · Cited by 44
“Functional mitochondrial studies have shown that energetic metabolism is correlated with the expression of MFN2 [ 11 ].”
BackgroundPeroxisome proliferator-activated receptor δ regulates mitofusin 2 expression in the heart
Li, Y., Yin, R., Liu, J., Wang, P., Wu, S., Luo, J., Zhelyabovska, O., & Yang, Q. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.020 · Cited by 37
A role for skeletal muscle stearoyl‐CoA desaturase 1 in control of thermogenesis
Mainieri, D., Summermatter, S., Seydoux, J., Montani, J.-P., Rusconi, S., Russell, A. P., Boss, O., Buchala, A. J., Dulloo, A. G., Mainieri, D., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5934fje · Cited by 36
Singh, S. P., Bellner, L., Vanella, L., Cao, J. J., Falck, J. R., Kappas, A., & Abraham, N. G. (2016) · Journal of Nutrition and Metabolism · doi:10.1155/2016/9039754 · Cited by 37
“Studies of the balance between fission and fusion have shown that development of obesity and insulin resistance is associated with a reduction in mitochondrial fusion [26, 29, 30] and increased mitochondrial fission [31].”
BackgroundGundersen, A. E., Kugler, B. A., McDonald, P. M., Veraksa, A. N., Houmard, J. A., & Zou, K. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0208 · Cited by 35
Tuning mitochondrial structure and function to criticality by fluctuation-driven mechanotransduction
Bartolák‐Suki, E., & Suki, B. (2020) · Scientific Reports · doi:10.1038/s41598-019-57301-1 · Cited by 36
Mitochondrial DNA Content in Human Omental Adipose Tissue
Lindinger, A., Peterli, R., Peters, T. T. A., Kern, B. E., von Flüe, M., Calame‐Christe, M., Hoch, M., Eberlé, A. N., & Lindinger, P. W. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9987-3 · Cited by 42
“, mfn2) [20], leading to a more fragmented population of mitochondria and, therefore, to a higher mitochondrial content per cell [21].”
BackgroundEarly protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney
Tang, W. X., Wu, W. H., Zeng, X., Bo, H., & Huang, S. (2011) · Endocrine · doi:10.1007/s12020-011-9555-1 · Cited by 37
MISC-1/OGC Links Mitochondrial Metabolism, Apoptosis and Insulin Secretion
Gallo, M., Park, D., Luciani, D. S., Kida, K., Palmieri, F., Blacque, O. E., Johnson, J. D., & Riddle, D. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017827 · Cited by 37
Unraveling Biochemical Pathways Affected by Mitochondrial Dysfunctions Using Metabolomic Approaches
Demine, S., Reddy, N., Renard, P., Raes, M. J., & Arnould, T. (2014) · Metabolites · doi:10.3390/metabo4030831 · Cited by 43
“In accordance with studies performed on animal models, the Mfn2 level is also reduced in T2DM patients’ skeletal muscle [213,223].”
BackgroundResultInsulin resistance is improved in high‐fat fed mice by photobiomodulation therapy at 630 nm
Silva, G., Ferraresi, C., Almeida, R. T., Motta, M. L., Paixão, T., Ottone, V. O., Fonseca, I. A. T., Oliveira, M. X., Rocha‐Vieira, E., Dias‐Peixoto, M. F., et al. (2019) · Journal of Biophotonics · doi:10.1002/jbio.201960140 · Cited by 39
Maternal transmission of mitochondrial diseases
Chiaratti, M. R., Macabelli, C. H., Neto, J. D. A., Grejo, M. P., Pandey, A. K., Perecin, F., & del Collado, M. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2019-0095 · Cited by 37
“As a result, perturbations in mitochondrial function may dramatically disturb cellular homeostasis, resulting in several common diseases in humans (Bach et al., 2003; Chen et al., 2007, 2010; Schaefer et al., 2008; Misko et al., 2012; Schon et al., 2012; Sebastian et al., 2012; Eschbach et al., 2013; Payne et al., 201…”
BackgroundBader, S., Wilmers, J., Pelzer, M., Jendrossek, V., & Rudner, J. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.024 · Cited by 37
Xu, L., Xu, C., Liu, X., Li, X., Li, T., Yu, X., Xue, M., Yang, J., Kosmas, C. E., Moris, D., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.745058 · Cited by 34
Mitochondrial Quality Control: the Role in Cardiac Injury
Sygitowicz, G., & Sitkiewicz, D. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703096 · Cited by 37
“in skeletal muscles of obese ZDF (Zucker diabetic fatty) rats [63].”
BackgroundAstrogliosis and glial scar in ischemic stroke - focused on mechanism and treatment
Chen, W., Su, G., Chai, M., An, Y., Song, J., & Zhang, Z. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115131 · Cited by 40
Thrush, A. B., Dent, R., McPherson, R., & Harper, M. (2013) · FEBS Journal · doi:10.1111/febs.12399 · Cited by 41
Epigallocatechin gallate counteracts oxidative stress in docosahexaenoxic acid-treated myocytes
Casanova, E., Baselga‐Escudero, L., Ribas‐Latre, A., Arola‐Arnal, A., Bladé, C., Arola, L., & Salvadó, M. J. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2014.01.014 · Cited by 36
Xu, Z., Zhang, L., Li, X., Jiang, Z., Sun, L., Zhao, G., Zhou, G., Zhang, H., Shang, J., & Wang, T. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv061 · Cited by 34
RNA binding protein HuD contributes to β-cell dysfunction by impairing mitochondria dynamics
Hong, Y., Tak, H., Kim, C., Kang, H., Ji, E., Ahn, S., Jung, M., Kim, H. L., Lee, J. H., Kim, W., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0447-x · Cited by 35
Ryu, S., Han, E. C., Yoon, J. W., & Choi, C. (2014) · Molecules and Cells · doi:10.14348/molcells.2015.2285 · Cited by 35
“Studies have demonstrated the relevance of mitochondrial dynamics for mitochondrial activity and metabolism (Bach et al., 2003; Pich et al., 2005).”
Mitofusin-2 in nucleus accumbens D2-MSNs regulates social dominance and neuronal function
Ghosal, S., Gebara, E., Ramos‐Fernández, E., Chioino, A., Grosse, J., de Suduiraut, I. G., Zanoletti, O., Schneider, B. L., Zorzano, A., Astori, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112776 · Cited by 36
Self-citationMitochondrial Dysfunction and Metabolic Reprogramming in Obesity and Asthma
Hartsoe, P., Holguín, F., & Chu, H. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052944 · Cited by 40
“This decrease in Mfn2 expression could contribute to the metabolic reprogramming seen in individuals who are obese since fragmentation has been associated with an increase in mitophagy [50].”
Backgroundde la Escalera, L. M., Kyrou, I., Vrbíková, J., Hainer, V., Šrámková, P., Fried, M., Piya, M. K., Kumar, S., Tripathi, G., & McTernan, P. G. (2017) · BMC Medicine · doi:10.1186/s12916-017-0797-5 · Cited by 34
“Moreover, fragmentation of muscle mitochondria has been reported in several mouse and human models of obesity and type-2 diabetes [42, 43].”
BackgroundEshima, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.758316 · Cited by 34
“Indeed, many studies have shown that HFD-induced obese rodents displayed no changes in SERCA activity and protein content (Bal et al., 2012; Fajardo et al., 2017; Eshima et al., 2017b; Gamu et al., 2019).”
BackgroundMSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer
Chen, Z., Xu, P., Wang, X., Li, Y., Yang, J., Xia, Y., Wang, S., Liu, H., Xu, Z., & Li, Z. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216235 · Cited by 36
Vadnais, M. L., Lin, A. M., & Gerton, G. L. (2014) · Cilia · doi:10.1186/2046-2530-3-5 · Cited by 35
Dynamic regulation of mitochondrial function in preimplantation embryos and embryonic stem cells
Harvey, A. J., Gibson, T. C., Lonergan, T. A., & Brenner, C. A. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.12.013 · Cited by 39
The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells
Sorianello, E. M., Soriano, F. X., Fernández‐Pascual, S., Sancho, A., Naón, D., Vila-Caballer, M., Navarro, H. G., Portugal, J., Andrés, V., Palacín, M., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs006 · Cited by 34
“As an example, we show a 41 bp gDNA fragment (2107 to 267) of the rat Mfn2 promoter region containing four CpG sites (Figure 2E, first sequence), the same sequence after Figure 2 Lack of methylation of the 5′-flanking region of human Mfn2.”
BackgroundInfluentialSelf-citationTak, H., Eun, J. W., Kim, J., Park, S. J., Kim, C., Ji, E., Lee, H., Kang, H., Cho, D., Lee, K., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.90 · Cited by 31
“Proteins present in the pulldown material were studied by western blot analysis as described in Bach et al.(63)”
MethodBroatch, J. R., Petersen, A. C., & Bishop, D. J. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00434.2016 · Cited by 44
“Mfn2 is a mitochondrial GTPase that plays an important role in mitochondrial fusion, therefore contributing to the maintenance of the mitochondrial network (4).”
BackgroundMitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt/β‑catenin pathway
Pang, G., Xie, Q., & Yao, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10570 · Cited by 40
“Further studies have indicated that MFN2 is involved in the regulation of vascular smooth muscle cell proliferation, and it may serve a role in the pathophysiology of obesity and Charcot-Marie-Tooth disease (8,9).”
BackgroundWhat is bipolar disorder? A disease model of dysregulated energy expenditure
Mansur, R. B., Lee, Y. L., McIntyre, R. S., & Brietzke, E. M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.006 · Cited by 36
Longitudinal metabolic profiling of cardiomyocytes derived from human-induced pluripotent stem cells
Bekhite, M. M., Delgado, A. G., Menz, F., Kretzschmar, T., Wu, J. M. F., Bekfani, T., Nietzsche, S., Wartenberg, M., Westermann, M., Greber, B., et al. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0796-0 · Cited by 37
An evolutionary, or “Mitocentric” perspective on cellular function and disease
Brown, J. A., Sammy, M. J., & Ballinger, S. W. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101568 · Cited by 34
When the Balance Tips: Dysregulation of Mitochondrial Dynamics as a Culprit in Disease
Kyriakoudi, S., Drousiotou, A., & Petrou, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094617 · Cited by 33
Relationships between Exercise, Mitochondrial Biogenesis and Type 2 Diabetes
Joseph, A.-M., & Hood, D. A. (2014) · Medicine and Sport Science · doi:10.1159/000357335 · Cited by 31
Khoo, N. K. H., Mo, L., Zharikov, S., Kamga-Pride, C., Quesnelle, K., Golin-Bisello, F., Li, L., Wang, Y., & Shiva, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.009 · Cited by 30
Maneschi, E., Cellai, I., Aversa, A., Mello, T., Filippi, S., Comeglio, P., Bani, D., Guasti, D., Sarchielli, E., Salvatore, G., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.01.015 · Cited by 32
“Similar mitochondrial alterations have been observed in obese Zucker rats (Bach et al., 2003) and in obese and type 2 diabetic subjects (Kelley et al., 2002; Toledo et al., 2006).”
Mitofusin-2: A New Mediator of Pathological Cell Proliferation
Xin, Y., Li, J., Wu, W., & Liu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.647631 · Cited by 32
Mitofusin 2: A link between mitochondrial function and substrate metabolism?
Emery, J., & Ortiz, R. M. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.09.003 · Cited by 37
Xiong, Y., Zhao, Q., Gu, L., Liu, C., & Wang, C. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8258246 · Cited by 33
KONG, D., SONG, G., WANG, C., MA, H., REN, L., NIE, Q., ZHANG, X., & GAN, K. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1457 · Cited by 29
Aghaali, M., & Nazari, S. S. H. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0437 · Cited by 34
Dong, J., Loor, J. J., Zuo, R., Chen, X., Liang, Y., Wang, Y., Shu, X. Y., Sun, X., Jia, H., Liu, G., et al. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16544 · Cited by 35
Quercetin Affects Erythropoiesis and Heart Mitochondrial Function in Mice
Ruíz, L. M., Salazar, C., Jensen, E. L., Ruiz, P. A., Tiznado, W., Quintanilla, R. A., Barreto, M., & Elorza, Á. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/836301 · Cited by 29
Cho, H., Sung, D., Kim, B., & Ki, C. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00763.x · Cited by 29
Effect of Roux-en-Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity
Sacks, J., Mulya, A., Fealy, C. E., Huang, H., Mosinski, J. D., Pagadala, M. R., Shimizu, H., Batayyah, E., Schauer, P. R., Brethauer, S. A., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13600 · Cited by 28
“Disruptions in fusion-dependent mechanisms have been shown to occur in obesity, including reduced skeletal muscle Mfn2 expression in obese Zucker rats and humans compared to lean controls (Bach et al. 2003).”
BackgroundTang, H., Wei, W., Wang, W., et al. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.01.019 · Cited by 28
Haigh, J., New, L. E., & Filippi, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.580879 · Cited by 32
Mitochondrial Changes in Cancer
Rao, S. G. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_40 · Cited by 32
Ko, A.-R., & Kang, T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.004 · Cited by 29
“Since the morphological state of mitochondria is linked to their bioenergetics, impaired mitochondrial dynamics are relevant to various pathological conditions (Bach et al., 2003; Olichon et al., 2003; Chen et al., 2005; Benard and Rossignol, 2008; Archer, 2013).”
BackgroundSong, J., Lei, X., Jiao, W., Song, Y., Chen, W., Li, J., & Chen, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-26918-z · Cited by 28
Hernández‐Álvarez, M. I., Chiellini, C., Manco, M., Naón, D., Liesa, M., Palacín, M., Mingrone, G., & Zorzano, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1403-y · Cited by 30
“To this end we selected: (1) nuclear genes that regulate mitochondrial biogenesis such as PGC-1α (also known as PPARGC1A), PGC-1β (also known as PPARGC1B) and PPARδ (also known as PPARD); (2) genes that regulate mitochondrial metabolism and fusion such as MFN2 [19, 20]; (3) genes that regulate peroxisome proliferator-…”
BackgroundMethodSelf-citationMitochondrial genetics and obesity: evolutionary adaptation and contemporary disease susceptibility
Dunham‐Snary, K. J., & Ballinger, S. W. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.007 · Cited by 30
“Additionally, MFN2 gene expression is repressed in skeletal muscle of obese patients compared to lean, signifying the role of mitochondrial dynamics in metabolism and obesity [84].”
InfluentialChanges in the expression of cardiac mitofusin-2 in different stages of diabetes in rats
Gao, Q. F., Wang, X., Ye, H., Yu, Y., Kang, P., Wang, H., Guan, S., & Li, Z. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1002 · Cited by 28
“Elimination of Mfn2 in fibroblasts, L6E9 myotubes or Opa1 in mouse embryonic fibroblasts increased mitochondrial fission and decreased mitochondrial membrane potential, oxygen consumption, glucose and palmitate oxidation as well as respiratory complex activity (11-13).”
BackgroundZhang, X., Wang, C., Song, G., Gan, K., Kong, D., Nie, Q., & Ren, L. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-45 · Cited by 33
“MFN2 is abundantly expressed in skeletal muscle [14-16] and its activity is crucial in the maintenance of mitochondrial tubules in cultured muscle cells [17].”
BackgroundSegalés, J., Paz, J. C., Hernández‐Álvarez, M. I., Sala, D., Muñoz, J. P., Noguera, E., Pich, S., Palacín, M., Enríquez, J. A., & Antonio Zorzano, A. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00546.2012 · Cited by 29
“Thus, Mfn2 has pleiotropic cellular roles and regulates cell proliferation, oxidative metabolism, autophagy, and mitochondrial antiviral signaling protein (4, 13, 22, 37, 51).”
BackgroundResultSelf-citationClinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma
Wu, Y., Zhou, D., Xu, X., Zhao, X., Huang, P., Zhou, X., Song, W., Guo, H., Wang, W., & Zheng, S. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0922-5 · Cited by 30
Wolf, C., Zimmermann, R., Thaher, O., Bueno, D., Wüllner, V., Schäfer, M. K. E., Albrecht, P., & Methner, A. (2019) · Cells · doi:10.3390/cells8101289 · Cited by 30
“It needs to be pointed out, however, that others reported a reduced mitochondrial membrane potential, cellular respiration and leak after down-regulation by antisense oligonucleotides in myoblasts [5] or in heart mitochondria obtained from MFN2−/− mice.”
BackgroundKoo, J., & Kang, E. (2019) · Physical Activity and Nutrition · doi:10.20463/jenb.2019.0005 · Cited by 27
Pereira, S. P., Tavares, L. C., Duarte, A. I., Baldeiras, I., Cunha‐Oliveira, T., Martins, J. D., Santos, M. S., Maloyan, A., Moreno, A. J., Cox, L. A., et al. (2021) · Clinical Science · doi:10.1042/cs20201339 · Cited by 27
Molecular evolution of proteins mediating mitochondrial fission–fusion dynamics
Sinha, S., & Manoj, N. (2019) · FEBS Letters · doi:10.1002/1873-3468.13356 · Cited by 32
Cellular mechanism of immobilization-induced muscle atrophy: A mini review
Ji, L. L., & Yeo, D. (2019) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2019.08.004 · Cited by 27
Beclin‐1 improves mitochondria‐associated membranes in the heart during endotoxemia
Sun, Y., Cai, Y., Qian, S., Chiou, H., & Zang, Q. S. (2020) · FASEB BioAdvances · doi:10.1096/fba.2020-00039 · Cited by 25
Ehrlicher, S. E., Stierwalt, H. D., Newsom, S. A., & Robinson, M. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651211 · Cited by 25
Kim, M. J., Nikouee, A., Sun, Y., Zhang, Q.-J., Liu, Z., & Zang, Q. S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.796061 · Cited by 28
Liu, Y., Guo, Z., Li, J., Li, A., & Huo, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113968 · Cited by 28
Mitofusin-2: Functional switch between mitochondrial function and neurodegeneration
Kulkarni, P. G., Mohire, V. M., Bhaisa, P. K., Joshi, M., Puranik, C. M., Waghmare, P. P., & Banerjee, T. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.02.001 · Cited by 27
Do we age because we have mitochondria?
Bereiter‐Hahn, J. (2013) · PROTOPLASMA · doi:10.1007/s00709-013-0515-x · Cited by 28
A novel mitofusin 2 mutation causes canine fetal-onset neuroaxonal dystrophy
Fyfe, J. C., Al-Temaimi, R. A., Liu, J., Schäffer, A. A., Agarwala, R., & Henthorn, P. S. (2011) · Neurogenetics · doi:10.1007/s10048-011-0285-6 · Cited by 27
Butterfield, D. A., Palmieri, E. M., & Castegna, A. (2016) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1149470 · Cited by 27
“Finally, the shift between fusion and fission is one of major regulatory mechanism that takes part in the dynamism of the mitochondrial network; indeed complex and divergent stimuli influence the mitochondrial appearance [33,34].”
Kuo, H.-M., Weng, S., Chang, A. Y., Huang, H., Lin, H., Chuang, J., Lin, T., Liou, C., Tai, M.-H., Lin, C., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.019 · Cited by 27
Axonal transport in a peripheral diabetic neuropathy model: sex-dimorphic features
Pesaresi, M., Giatti, S., Spezzano, R., Romano, S., Diviccaro, S., Borsello, T., Mitro, N., Caruso, D., García‐Segura, L. M., & Melcangi, R. C. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0164-z · Cited by 26
“Previous works showed that MFN2 expression is reduced in patients with obesity or type 2 diabetes as well as in obese Zucker rats, a model of type 2 diabetes, suggesting that mitochondrial fusion is an important factor in the pathophysiology of these disorders [59, 60].”
BackgroundKugler, B. A., Gundersen, A. E., Li, J., Deng, W., Eugene, N., Gona, P. N., Houmard, J. A., & Zou, K. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0469-y · Cited by 24
“dynamics towards fission has been linked to increased glycolysis [19] and impaired glucose oxidation [14].”
BackgroundThonusin, C., Apaijai, N., Jaiwongkam, T., Kerdphoo, S., Arunsak, B., Amput, P., Palee, S., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114741 · Cited by 26
Kolaç, U. K., Eken, M. K., Ünübol, M., Dönmez, G., & Yalçın, A. (2021) · Placenta · doi:10.1016/j.placenta.2021.09.015 · Cited by 26
Mitofusin 2 Protects Hepatocyte Mitochondrial Function from Damage Induced by GCDCA
Chen, Y., Lv, L., Jiang, Z., Yang, H., Li, S., & Jiang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065455 · Cited by 24
“For example, Mfn2 suppression leads to the fragmentation of the mitochondrial network and is associated with decreased mitochondrial membrane potential and defects in ATP synthesis, whereas the induction of Mfn2 increases glucose oxidation and restores ATP levels [36,37,38].”
BackgroundThe ARL2 GTPase regulates mitochondrial fusion from the intermembrane space
Newman, L. E., Schiavon, C. R., Turn, R. E., & Kahn, R. (2017) · Cellular Logistics · doi:10.1080/21592799.2017.1340104 · Cited by 25
The Causal Role of Mitochondrial Dynamics in Regulating Innate Immunity in Diabetes
Chang, Y., Lin, H., Shen, F., Su, Y., Chuang, J., Lin, T., Liou, C., Lin, C., Weng, S., & Wang, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00445 · Cited by 24
Metadata
- Authors
- Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., Rabasa-Lhoret, R., Wallberg-Henriksson, H., Laville, M., Palacı́n, M., Vidal, H., Rivera, F., Brand, M., & Zorzano, A.
- Affiliations
- Parc Científic de Barcelona (ES)
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
- Karolinska University Hospital (SE)
- Inserm (FR)
- MRC Mitochondrial Biology Unit (GB)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 19
- Pages
- 17190-17197
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127806759
- Cited by
- 832
- References
- 50
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 28 · 2023: 49 · 2022: 32 · 2021: 40 · 2020: 63 · 2019: 45 · 2018: 52 · 2017: 45 · 2016: 48 · 2015: 32 · 2014: 47 · 2013: 49 · 2012: 54
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6378 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- mitofusin 2, mitochondrial fusion, mitochondrial metabolism, myogenesis, muscle mitochondria, mitochondrial fragmentation, glucose oxidation, mitochondrial membrane potential, cellular respiration, mitochondrial proton leak, obesity, mitochondrial membrane proteins
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Membrane Potentials, Membrane Proteins, Middle Aged, Mitochondria, Muscle, Obesity, Rats, Zucker, Muscle, Skeletal, GTP Phosphohydrolases, Mitochondrial Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.